#United States #New York #Faruqi & Faruqi #Nano-X Imaging #NNOX

Important Deadline for Nano-X Imaging Investors

The legal landscape for investors in Nano-X Imaging Ltd. (NASDAQ: NNOX) is heating up, as the deadline to join a federal securities class action lawsuit is fast approaching. Investors have until August 11, 2026, to potentially serve as lead plaintiffs in this significant case filed against the company.

Background of the Lawsuit

Faruqi & Faruqi, LLP, a respected national securities law firm, is spearheading this investigation into Nano-X Imaging. The lawsuit arises from serious allegations that Nano-X misrepresented its operational efficiency and financial health over a certain period. Specifically, the complaint suggests that Nano-X and its executives made misleading statements regarding their production and demand for products, leading to investor losses.

Allegations Against Nano-X

The class action against Nano-X Imaging alleges multiple points of wrongdoing by the company:
1. Overstated Efficiency Gains: The company is accused of exaggerating its operational effectiveness, which may have lured investors into believing in the viability of its business model.
2. Misleading Financial Statements: It is claimed that Nano-X failed to disclose the true state of its manufacturing operations, which were allegedly poorly aligned with the actual demand for its products. This misalignment may have increased operational costs and cash burn significantly.
3. Impending Restructuring: As per the allegations, Nano-X was forced to undertake a costly restructuring initiative to realign its operations, resulting in significant impairment charges.
4. False Public Statements: The lawsuit emphasizes that Nano-X’s public declarations were materially false and misleading at critical times, thus failing its fiduciary duty to shareholders.

Financial Impact on Investors

In a press release dated April 20, 2026, Nano-X disclosed a disappointing net loss of $33.4 million for the fourth quarter of 2025, a loss exacerbated by charges related to asset impairment due to its restructuring efforts. This information led to a substantial drop in the stock price—24.39%, to close at $2.1550 per share—prompting further scrutiny from investors.

Participation in the Class Action

Given the gravity of the allegations, affected investors who acquired or purchased Nano-X securities between March 31, 2025 and April 17, 2026 may be eligible to participate in this lawsuit. Those individuals who have suffered losses during this period should act quickly to review their options.

To take part in the action, interested parties must file a motion with the court to request appointment as lead plaintiff. Notably, serving as a lead plaintiff can provide additional influence over the litigation process, but investors can still share in the recovery of any settlement without taking on this role.

Contact Information and Next Steps

Faruqi & Faruqi, LLP is encouraging investors or anyone with pertinent information about Nano-X’s practices to reach out directly. Potential plaintiffs can contact Josh Wilson, a Partner at the firm, through two dedicated phone lines: 877-247-4292 or 212-983-9330 (Ext. 1310).

For more detailed information about the case or the class action process, investors can visit Faruqi & Faruqi’s website. It is crucial for investors to keep records of their transactions and maintain related documents, as these may be relevant should they decide to join the lawsuit.

Conclusion

Nan-X Imaging's legal troubles underline the risks involved in investing, particularly when companies face allegations of misleading financial disclosures. Investors should stay informed and consider their legal options carefully before the August 11, 2026 deadline. Staying proactive could mean the difference between recovery and loss regarding their investments in Nano-X Imaging.